News & Events about Deciphera Pharmaceuticals Inc.
Business Wire
3 months ago
Deciphera Pharmaceuticals, Inc. (NASDAQ: DCPH), a biopharmaceutical company focused on discovering, developing, and commercializing important new medicines to improve the lives of people with cancer, today announced that members of the management team will participate in fireside chats at the...
Market News Video
3 months ago
In trading on Thursday, shares of Deciphera Pharmaceuticals Inc (DCPH) crossed below their 200 day moving average of 15.37, changing hands as low as 14.88 per share. Deciphera Pharmaceuticals Inc shares are currently trading off about 2.3% on the day...
Ticker Report
4 months ago
Deciphera Pharmaceuticals, Inc. (NASDAQ:DCPH Get Rating) major shareholder Brightstar Associates Llc bought 1,666,666 shares of Deciphera Pharmaceuticals stock in a transaction that occurred on Tuesday, January 24th. The shares were acquired at an average cost of $18.00 per share, for a ...